Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Brain Metabolic Profile in Presymptomatic GRN Carriers Throughout a 5-Year Follow-up.
Neurology. 2023 Jan 24;100(4):e396-e407. doi: 10.1212/WNL.0000000000201439. Epub 2022 Oct 18.
Neurology. 2023.
PMID: 36257714
Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications.
Saracino D, Dorgham K, Camuzat A, Rinaldi D, Rametti-Lacroux A, Houot M, Clot F, Martin-Hardy P, Jornea L, Azuar C, Migliaccio R, Pasquier F, Couratier P, Auriacombe S, Sauvée M, Boutoleau-Bretonnière C, Pariente J, Didic M, Hannequin D, Wallon D; French Research Network on FTD/FTD-ALS; PREV-DEMALS and Predict-PGRN study groups; Colliot O, Dubois B, Brice A, Levy R, Forlani S, Le Ber I.
Saracino D, et al.
J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1278-1288. doi: 10.1136/jnnp-2021-326914. Epub 2021 Aug 4.
J Neurol Neurosurg Psychiatry. 2021.
PMID: 34349004
Free PMC article.
Item in Clipboard
Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings.
Soret M, Maisonobe JA, Desarnaud S, Bergeret S, Causse-Lemercier V, Berenbaum A, Rozenblum L, Habert MO, Kas A.
Soret M, et al. Among authors: causse lemercier v.
Sci Rep. 2022 Sep 12;12(1):15341. doi: 10.1038/s41598-022-18029-7.
Sci Rep. 2022.
PMID: 36097015
Free PMC article.
Item in Clipboard
Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds.
Habert MO, Bertin H, Labit M, Diallo M, Marie S, Martineau K, Kas A, Causse-Lemercier V, Bakardjian H, Epelbaum S, Chételat G, Houot M, Hampel H, Dubois B, Mangin JF; INSIGHT-AD study group.
Habert MO, et al. Among authors: causse lemercier v.
Ann Nucl Med. 2018 Feb;32(2):75-86. doi: 10.1007/s12149-017-1221-0. Epub 2017 Dec 7.
Ann Nucl Med. 2018.
PMID: 29218458
Item in Clipboard
Interim FDG-PET improves treatment failure prediction in primary central nervous system Lymphoma: a LOC network prospective multicentric study.
Rozenblum L, Houillier C, Baptiste A, Soussain C, Edeline V, Naggara P, Soret M, Causse-Lemercier V, Willems L, Choquet S, Ursu R, Galanaud D, Belin L, Hoang-Xuan K, Kas A.
Rozenblum L, et al. Among authors: causse lemercier v.
Neuro Oncol. 2024 Feb 16:noae029. doi: 10.1093/neuonc/noae029. Online ahead of print.
Neuro Oncol. 2024.
PMID: 38366824
Item in Clipboard
[18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC network.
Rozenblum L, Galanaud D, Houillier C, Soussain C, Baptiste A, Belin L, Edeline V, Naggara P, Soret M, Causse-Lemercier V, Willems L, Choquet S, Ursu R, Hoang-Xuan K, Kas A.
Rozenblum L, et al. Among authors: causse lemercier v.
Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3684-3696. doi: 10.1007/s00259-023-06334-w. Epub 2023 Jul 18.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 37462774
Item in Clipboard
Cite
Cite